Introduction
A tripeptide, thyroptropin-releasing hormone (TRH), isolated from hypothalamic tissue has the ability to stimulate release of thyrotropin (TSH) from the pituitary both in vivo and in vitro (Schalley et al., 1966; 1968; Burgus et al., 1969) . In addition, exogenous TRH also stimulates release of prolactin (PRL) in most species studied (Davis and Borger, 1972; Convey et al., 1973; Bowers et al., 1973) and, in some cases, growth hormone (GH) Convey et al., 1973 ; Davis et al., 1976) . However, it is not known if TRH is a physiological regulator of either PRL or GH secretion. Elucidation of the physiological actions of TRH is partially dependent upon definition of its endogenous secretory pattern, which requires a sensitive and specific assay system for TRH in biological fluids. Plasma hormone concentration is a function of both secretion rate of the hormone and its rate of clearance from the circulation. The estimation of these physiological parameters is dependent upon knowledge of the I Idaho Agricultural Experiment Station Pub. No. 78410. 2These studies were conducted in partial fulfillment of the requirements for the PH.D. degree at Washington State University under support by the University of Idaho Agricultural Experiment Station, and in part by grants from the National Institutes of Health (HD 07830) and, Merck Institute for Theraputic Research, Rahway, NJ.
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Materials and Methods
Immunizations. Thyrotropin-releasing hormone (TRH) conjugated to bovine serum albumin (BSA) by the bis-diazotized-benzidine (BDB) method (Bassiri and Utiger, 1972a ) was prepared and kindly supplied by Dr. G. D. Niswender. The TRH-BDB-BSA conjugate (1.0 mg) was emulsified in complete Freund's adjuvant and injected intradermally into rabbits at multiple sites along their backs (Midgley et al., 1971) . Thereafter, injections in incomplete Freund's adjuvant were administered at 3-to 4-week intervals. Blood was collected via ear vein incision 2 weeks after each booster injection. Antisera from each bleeding were titered by binding analysis (Midgley et al., 1971) . Anti-rabbit gamma globulin was prepared in sheep as described previously (Niswender et al., 1969) .
Radioiodination of TRH. Radioiodinated TRH was prepared by a modification of the previously described procedure for luteinizing hormone (LH) (Niswender et al., 1969) employing 2.5 /~g synthetic TRH (Abbott, Lot 23-256), 15 /ag chloramine-T, .5 mCi high specific activity carrier free sodium 12s iodine in dilute sodium hydroxide, 30-sec reaction time, and 125 /lg sodium metabisulfite. Radioiodinated TRH and free 12Sl were separated immediately after the radioiodination reaction on .7 x 12 cm columns of Sephadex | G-10. The columns were prepared and eluted with .01 M phosphate-buffered saline (PBS). Prior to use the columns were washed with 1 ml PBS-5% BSA. An initial nonimmunoreactive fraction, 1165 JOURNAL OF ANIMAL SCIENCE, Vol. 48, No. 5 (1979) which may represent an aggregation product, was eluted in 2.0 ml to 4.0 milliliters. The immunoreactive I2SI-TRH, with an estimated specific activity of 158 //Ci//ag (Greenwood et al., 1963; A. R. Midgley and G. D. Niswender, unpublished) was eluted in 5.0 to 7.5 ml (figure 1). Just prior to use in an assay, the tzSI-TRH was repurified on a 2.6 x 12 cm column of Sephadex| G-10 prepared and eluted as described above. Highly immunoreactive 12s I-TRH was obtained from the descending limb of the elution curve ( figure 2) .
Radioimmunoassay of TRH. The radioimmunoassay of TRH was performed using a procedure similar to that described for LH (Niswender et al., 1969) , except that it was an equilibrium system (Midgley et al., 1971) in which the sample, antisera, and labelled hormone were added at the initiation of the assay. Preliminary studies had shown that the pres- 0 S 10 1S s VOLUME Ioooi) Figure 1 . Separation of immunoreactive ~2s [-TRH from the radioiodination reagents on .7 X 12 cm column of Sephadex | G-10. The three peaks represent a possible aggregation product (2.0 ml to 4.0 ml), immunoreactive t2s I-TRH (5.0 ml to 7.5 ml), and free 12s I (9.0 ml to 15.0 ml).
ence of plasma in the assay tubes apparently enhanced antibody binding of the hormone. Therefore, 300/al of TRH-free plasma, prepared by incubation of normal plasma at 37 C for 24 hr (Bassiri and Utiger, 1972b; Saito et al., 1975) was added to both standard curve and background tubes. Each assay tube received 300 /~1 of sample plasma, 300 /~1 of PBS-I% BSA, 100/al of anti-TRH sera (diluted 1:600), and 100/~1 of ]2s I-TRH in PBS~ BSA (approximately 40,000 cpm) and allowed to incubate at 4 C for 24 hours. Then 200/ll of antirabbit gamma globulin were added and the assay incubated for an additional 72 hr at 4 C prior to addition of 2.5 ml PBS. Antibody bound and free ]2s I-TRH were separated by centrifugation. The supernatant was discarded and the radioactivity bound to the anti-TRH, which was in the precipitate, was quantified with an automatic gamma spectrometer. Assay parameters and TRH concentration in samples were calculated using a computer method (Duddleson et aL, 1972) . This method utilized a weighted regression equation of the logit values of the specific radioactivity bound in the standard curve tubes as a proportion of the specific radioactivity bound in the buffer control tubes (Midgley et aL, 1971 ) that contained no unlabelled TRH plotted against the logarithm of TRH dose. Plasma Collection for TRH RIA. Blood was collected and immediately placed into centrifuge tubes containing 10 IU sodium heparin plus .75 mg (calculated on the basis of specific gravity) BAL (2, 3-dimercaptopropanol, Sigma) dispersed in water with .4 mg Tween 20 (polyoxyethylene sorbitan monolaurate, Sigma) per ml of blood and placed on ice. The BAL was added to prevent enzymatic degradation of TRH by plasma enzymes (Saito et al., 1975; Mitsuma et al., 1976) . The enzyme inhibitor was dispensed into tubes to be used for blood collection as 100 gtl of an aqueous solution just prior to sample collection. Blood sample volume was 5 to 10 ml, so the effect of dilution by the inhibitor was assumed to be negligible. Blood samples were kept at 4 C until centrifugation and collection of plasma (up to 16 hr). Plasma was stored at -20 C until assayed.
Clearance of TRH. Four western whiteface ewes (approximately 58 kg BW and 19 months of age), ovariectomized approximately 8 months previously, were placed in metabolism crates in an unheated building. Average temperature was approximately 15 C, and natural autumnal photoperiod was maintained. They were fed 2 kg of a pelleted complete ration at 1700 hr daily. Water was provided ad libitum. After a 2-week adaptation period, the animals were removed from the metabolism crates, anesthetized with sodium thiopental (10 mg/kg) and jugular cannulae inserted. The following day, at 1300 hr, blood samples were collected for TRH assay. After collection for pre-injection samples, 50 gtg synthetic TRH (Calbiochem, Lot 600659) was injected via jugular cannula into each animal. Blood samples were also collected, with only sodium heparin added, for measurement of TSH (Borger and Davis, 1974) to assess the physiological effect of the TRH injection. The TSH reference preparation was NIH-TSH-S6 (2.47 USP units/ rag).
The t 89 of exogenous TRH was calculated for each component of the disappearance curve in the following form (Stanford, 1975) :
where C = plasma concentration of TRH at t=0 C t = plasma concentration of TRH at t>O ;k = constant of proportionality or rate constant, equal to -1 times the slope of the regression equation t = time after injection of exogenous TRH Since t 89 is by definition that time when C t = .5 C, t 89 can be calculated by the equation:
in (C/.5C) t 89 X The non-linear regression equation of the two-pool disappearance curve was calculated using a least squares computer method (Barr et al., 1976) .
where Y =TRH concentration/liter + total TRH dose injected A = y intercept of the first component of the disappearance curve a = rate constant of the first component of the disappearance curve B = y intercept of the second component of the disappearance curve 13 = rate constant of the second component of the disappearance curve t = time after injection of TRH These parameters were used to calculate MCR using the two-pool model for a single injection (Tait and Burstein, 1964) where clearance is from both pools:
Results
Antisera of sufficient titer for use in an assay system were produced in two of six rabbits injected with TRH-BDB-BSA conjugate within 6 months after initiation of the immunizations. In the assay, a working dilution of the antisera at 1:600 bound 25% to 30% of the radioactivity in the buffer control tubes.
Specificity of the antisera was checked against gonadotropin-releasing hormone (GnRH) and somatostatin and possible fragments of TRH (table 1) . None of these peptides demonstrated any ability to inhibit x2SI-TRH binding to the antisera. Lack of deviation from parallelism between the TRH reference preparation, other preparations of synthetic TRH and dilutions of plasma collected from sheep injected with synthetic TRH suggests that these bind to the antibody with similar affinity (figure 3). Sensitivity of the assay system was estimated as, the least amount of TRH that resulted in significantly less binding of 12s I-TRH than in the buffer control tubes. In six assays this value averaged 1.25 + .38 pg/tube with a range of .57 pg/tube to 3.08 pg/tube.
TRH is rapidly degraded in plasma and serum (Bassiri and Utiger, 1972b; Saito et al., 1975) . The labile nature of TRH in plasma has also been observed in our laboratory. Therefore, an enzyme inhibitor was added to blood samples at the time of collection to prevent enzymatic degradation of the hormone. Several enzyme inhibitors were evaluated (table 2) for this purpose. It was found that .75 mg BAL, dispersed in water with .4 mg Tween 20, effectively prevented TRH degradation without excessive interference in the assay and was relatively convenient to use. The ability of the assay system to measure known amounts of reference preparation in plasma from blood treated with BAL and Tween 20 was assessed in four assays. The resultant values, corrected for the endogenous TRH, produced a recovery curve whose slope was 1.002 with an intercept of 3.98 and correlation coefficient of .99 ( figure 4) .
Precision of the assay system was evaluated by calcul~ttion of the coefficient of variation between samples measured in different assays. This interassay variation was 22.6% when determined from assay of eight plasma samples with TRH concentration ranging from 16.8 pg/ml to 427.7 pg/ml in four assays. The intraassay variation estimated with a sample containing no exogenous TRH was 5.8%.
Plasma concentrations of TRH were greatly elevated in samples collected from ovariectomized ewes after iv injection of 50/lg TRH (figure 5) . This disappearance curve indicated that there are two pools of distribution of TRH within the animal. During the 10-min period prior to injection of TRH, the apparent mean plasma concentration was 11.3 + 3.0 pg/milliliter. Four min after injection of exogeneous TRH the levels ranged from 1090 pg/ml to 2150 pg/ml with a mean (+SE) of 1650 + 220.9 pg/millileters. Estimated t 89 of exogenous TRH, assuming a one component disappearance curve, was 31.9 + 3.2 minutes. However, a better fit of the logarithms of the temporal concentrations to a linear regression line was achieved using a two component disappearance curve. The best fit (highest correlation coefficients) was achieved when the two linear components of the disappearance curve were considered to be 4 to 36 rain for the first and 40 to 120 min for the second component. The estimated t 89 for the first linear component was 20.0 +-3.2 minutes. For the second linear component the t 89 was 44.4 + 2.9 minutes. Using the rate constants of the nonlinear regression equations, the t 89 was 6.9 + 3.1 anti aThe inhibitors were added to whole blood when it was collected from one animal. The blood was stored at 4 C 16 hr prior to eentrifugation and collection of the plasma which was stored at -20 C until assay. Varying quantities of reference TRH in 300 ~1 of PBS-I% BSA were added to 300 ~1 of plasma and incubated at 4 C for 10 hr prior to initiation of the assay. bBAL = 2, 3-dimercaptopropanol, Sigma.
CTween 20 = polyoxyethylene sorbitan monolaurate, Sigma.
d8-HQ = 8-hydroxyquinoline, Sigma.
42.4 + 9.3 min for the first and second components of the disappearance curve, respectively. The mean MCR of exogenous TRH in these animals was 54.2 -+ 6.3 liter/hour.
Temporal plasma concentrations of TSH presented in figure 5 demonstrates that the elevated TRH levels induced by injection of 50 gtg of the releasing-hormone were able to elicit an increase in plasma TSH. 
Discussion
The radioimmunoassay developed for :measurement of TRH in unextracted plasma using synthetic TRH for reference and radioiodina- tion preparations has a sensitivity suitable for detection of TRH immunoreactivity in the peripheral circulation. Apparent plasma concentrations of endogenous TRH in ovariectomized ewes ranged from 5.2 pg/ml to 62.0 pg/ml as measured by the present assay (Klindt et al., 1979) . In human subjects, plasma TRH concentrations were reported to be 19 pg/ml or less in normal subjects (Saito et aL, 1975) and 40 to 500 pg/ml in hypothyroid patients (Mitsuma et al., 1976) .
Estimates of t 89 of the first component of the disappearance curve calculated from the rate constants of the linear regression equations are not totally valid. The linear regression equations ignore the contribution of the other component which is included in each estimate. The first component of the disappearance curve had a t~ of 20.0 min using the linear regression equation. In contrast, when t 89 of the first component is calculated using the rate constant from the non-linear regression equation, the estimate is 6.9 minutes. This is a more accurate estimate and better represents the t 89 of the distribution phase of the disappearance curve. Estimates of t 89 derived from the rate constants of the linear regression equations are therefore presented here only for the sake of comparison with previously reported values.
The t 89 of each component of the disappearance curve of exogenous TRH estimated in these studies with sheep 20.0 min and 44.4 min, is considerably greater than those reported by other workers, 4 to 12 min (Saito et al., 1975) , 3 to 7 min (Sterling and Lazarus, 1977) , and 5.3 min (Bassiri and Utiger, 1973) in human subjects. The t 89 estimate, 5.3 min, of Bassiri and Utiger (1973) was based upon the first linear component, 0 to 20 min, of the 60 min disappearance curve following an iv injection of 400 /ag TRH. A visual analysis of the second component, where TRH levels declined from approximately 2 ng/ml to 1 ng/ml, suggests a t 89 approaching 30 min (figure 6). These levels are in the range of those observed in the present study during the first 12-min postinjection. The data presented in figure 6 suggest that the t 89 of TRH may be proportional to the plasma level of the hormone. In other work, with PRL, it has been suggested that the MCR is proportional to plasma PRL concentration (Davis and Borger, 1973) . Therefore, dosage employed may partially explain the differences between the present estimates in the ovine and previously reported estimates in Invest. 52:1616 Invest. 52: , 1973 the human. The t 89 estimated from the disappearance curve of 12Sl_TRH from the circulation of the rat was 22.6 min over a 30-min period (J. Klindt, unpublished data), a value that agrees with the present results (20 min). Saito et al. (1975) found up to 12.3% of a 500 /lg injection of TRH in the urine within 1 hr, indicating clearance by renal filtration. This ability of the kidney to clear exogenous TRH may be proportional to plasma concentration of the hormone. The level of renal clearance reported by these workers may reflect glomerular spill-over rather than the physiological mechanism of clearance. If this level of renal clearance does reflect glomerular spill-over, then these estimates of t 89 do not reflect the kinetics that would be observed with lower doses of TRH. The long t 89 of exogenous TRH estimated in the present study with sheep is surprising in view of the rapid disappearance of immunoreactive TRH in serum and plasma in vitro (Bassiri and Utiger, 1972b; Saito et al., 1975) . One possible explanation of the difference may be that in vivo TRH is bound to a serum carrier protein which protects it from degradation. However, this suggestion is not supported by previous studies in our laboratory, where a binding protein was not found based upon the inability of 3H-TRH to bind to a serum protein in vitro (J. Klindt, unpublished data) . An additional possibility is that the altered pH of a collected blood sample and the intracellular enzymes released from lysed cells in the collected sample may be acting alone or in concert to hasten degradation of TRH in vitro. A further possibility is that t 89 of TRH in sheep is truly different from that previously reported for rats and humans. The recent demonstration that t 89 of GnRH is different in sheep as compared to other species (Nett and Adams, 1977) would be consistent with this suggestion.
The calculated MCR of exogenous TRH administered by a single iv injection was 54.2 +-6.3 liter/hour. The MCR reported for TRH during constant infusion studies using similar sheep during the same season of the year was 69.5 liter/hr (Klindt et aL, 1979) .
The results of these studies suggest that TRH is considerably more stable in sheep blood than has been previously reported for other species.
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